<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37054916</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel.</ArticleTitle><Pagination><StartPage>2569</StartPage><EndPage>2584</EndPage><MedlinePgn>2569-2584</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtha.2023.02.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1538-7836(23)00274-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">COVID-19 severity and its late complications continue to be poorly understood. Neutrophil extracellular traps (NETs) form in acute COVID-19, likely contributing to morbidity and mortality.</AbstractText><AbstractText Label="OBJECTIVES">This study evaluated immunothrombosis markers in a comprehensive cohort of acute and recovered COVID-19 patients, including the association of NETs with long COVID.</AbstractText><AbstractText Label="METHODS">One-hundred-seventy-seven patients were recruited from clinical cohorts at 2 Israeli centers: acute COVID-19 (mild/moderate, severe/critical), convalescent COVID-19 (recovered and long COVID), along with 54 non-COVID controls. Plasma was examined for markers of platelet activation, coagulation, and NETs. Ex&#xa0;vivo NETosis induction capability was evaluated after neutrophil incubation with patient plasma.</AbstractText><AbstractText Label="RESULTS">Soluble P-selectin, factor VIII, von Willebrand factor, and platelet factor 4 were significantly elevated in patients with COVID-19 versus controls. Myeloperoxidase (MPO)-DNA complex levels were increased only in severe COVID-19 and did not differentiate between COVID-19 severities or correlate with thrombotic markers. NETosis induction levels strongly correlated with illness severity/duration, platelet activation markers, and coagulation factors, and were significantly reduced upon dexamethasone treatment and recovery. Patients with long COVID maintained higher NETosis induction, but not NET fragments, compared to recovered convalescent patients.</AbstractText><AbstractText Label="CONCLUSIONS">Increased NETosis induction can be detected in patients with long COVID. NETosis induction appears to be a more sensitive NET measurement than MPO-DNA levels in COVID-19, differentiating between disease severity and patients with long COVID. Ongoing NETosis induction capability in long COVID may provide insights into pathogenesis and serve as a surrogate marker for persistent pathology. This study emphasizes the need to explore neutrophil-targeted therapies in acute and chronic COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krinsky</LastName><ForeName>Nitzan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sizikov</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nissim</LastName><ForeName>Sivan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dror</LastName><ForeName>Adi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sas</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinz</LastName><ForeName>Hodaya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pri-Or</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perek</LastName><ForeName>Shay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine A, Rambam Health Care Campus, The Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raz-Pasteur</LastName><ForeName>Ayelet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine A, Rambam Health Care Campus, The Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lejbkowicz</LastName><ForeName>Izabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Epidemiology Department and Biobank, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen-Matsliah</LastName><ForeName>Sivan Ida</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Epidemiology Department and Biobank, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almog</LastName><ForeName>Ronit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Epidemiology Department and Biobank, Rambam Health Care Campus, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Nikanor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurd</LastName><ForeName>Ramzi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarjou'i</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rokach</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben-Chetrit</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Avi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caulin</LastName><ForeName>Aleah F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Peel Therapeutics, Inc, Salt Lake City, Utah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yost</LastName><ForeName>Christian Con</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Neonatology, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA; Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiffman</LastName><ForeName>Joshua D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Peel Therapeutics, Inc, Salt Lake City, Utah, USA; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA. Electronic address: jschiffman@peeltx.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldfeder</LastName><ForeName>Mor</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Peel Therapeutics Israel, Ltd, Nesher, Israel. Electronic address: mgoldfeder@peeltx.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinod</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Electronic address: kim.martinod@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HD093826</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thromb Haemost. 2023 Sep;21(9):2362-2364. doi: 10.1016/j.jtha.2023.06.005</RefSource><PMID Version="1">37597894</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065206" MajorTopicYN="Y">Extracellular Traps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">extracellular traps</Keyword><Keyword MajorTopicYN="N">immunothrombosis</Keyword><Keyword MajorTopicYN="N">neutrophil</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>Declaration of competing interests N.K., S.S., S.N., A.D., A.S., H.P., E.P., A.F.C., J.D.S., and M.G. are current or former employees of Peel Therapeutics and hold share options in the company. K.M. and A.S. received consulting fees for scientific advice to Peel Therapeutics and hold stock options in the company. C.C.Y. authors a US patent (patent no. 10,232,023 B2) held by the University of Utah for the use of NET-inhibitory peptides for the "treatment of and prophylaxis against inflammatory disorders," for which Peel Therapeutics, Inc. holds the exclusive license. C.C.Y. and J.D.S. are co-inventors on patent application WO2021226111A1 for NET-inhibitory peptides to treat and prevent immunothrombosis in COVID-19 acute respiratory distress syndrome. S.P., A.R.P, I.L., S.I.C.M., R.A., N.C., R.K., A.J., A.R. and E.B. have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37054916</ArticleId><ArticleId IdType="pmc">PMC10088279</ArticleId><ArticleId IdType="doi">10.1016/j.jtha.2023.02.033</ArticleId><ArticleId IdType="pii">S1538-7836(23)00274-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. World Health Organization. Available online: https://covid19.who.int/. Last updated: 13 September 2022. In: World Health Organization.</Citation></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouck E.G., Denorme F., Holle L.A., Middelton E.A., Blair A.M., de Laat B., Schiffman J.D., Yost C.C., Rondina M.T., Wolberg A.S., Campbell R.A. COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity. Arterioscler Thromb Vasc Biol. 2021;41:401&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7942774</ArticleId><ArticleId IdType="pubmed">33196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizurini D.M., Hottz E.D., Bozza P.T., Monteiro R.Q. Fundamentals in Covid-19-associated thrombosis: molecular and cellular aspects. Front Cardiovasc Med. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8718518</ArticleId><ArticleId IdType="pubmed">34977191</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Jiang L., Li X., Lin F., Wang Y., Li B., Jiang T., An W., Liu S., Liu H., Xu P., Zhao L., Zhang L., Mu J., Wang H., Kang J., Li Y., Huang L., Zhu C., Zhao S., Lu J., Ji J., Zhao J. Clinical and pathological investigation of patients with severe COVID-19. JCI Insight. 2020;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406259</ArticleId><ArticleId IdType="pubmed">32427582</ArticleId></ArticleIdList></Reference><Reference><Citation>McElvaney O.J., McEvoy N.L., McElvaney O.F., Carroll T.P., Murphy M.P., Dunlea D.M., N&#xed; Choile&#xe1;in O., Clarke J., O'Connor E., Hogan G., Ryan D., Sulaiman I., Gunaratnam C., Branagan P., O'Brien M.E., Morgan R.K., Costello R.W., Hurley K., Walsh S., de Barra E., et al. Characterization of the inflammatory response to severe Covid-19 illness. Am J Respir Crit Care Med. 2020;202:812&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491404</ArticleId><ArticleId IdType="pubmed">32584597</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton E.A., He X.Y., Denorme F., Campbell R.A., Ng D., Salvatore S.P., Mostyka M., Baxter-Stoltzfus A., Borczuk A.C., Loda M., Cody M.J., Manne B.K., Portier I., Harris E.S., Petrey A.C., Beswick E.J., Caulin A.F., Iovino A., Abegglen L.M., Weyrich A.S., et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A., Vecchi&#xe9; A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21:319&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Leunig A., Brambs S., Kaiser R., Weinberger T., Weigand M., Muenchhoff M., Hellmuth J.C., Ledderose S., Schulz H., Scherer C., Rudelius M., Zoller M., H&#xf6;chter D., Keppler O., Teupser D., Zwi&#xdf;ler B., von Bergwelt-Baildon M., K&#xe4;&#xe4;b S., Massberg S., et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020;142:1176&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7497892</ArticleId><ArticleId IdType="pubmed">32755393</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppkes M., Knopf J., Naschberger E., Lindemann A., Singh J., Herrmann I., St&#xfc;rzl M., Staats L., Mahajan A., Schauer C., Kremer A.N., V&#xf6;lkl S., Amann K., Evert K., Falkeis C., Wehrfritz A., Rieker R.J., Hartmann A., Kremer A.E., Neurath M.F., et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397705</ArticleId><ArticleId IdType="pubmed">32745993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura-Santana E., Ninan J.R., Snyder C.M., Okeke E.B. Neutrophil extracellular traps, sepsis and COVID-19 &#x2013; a tripod stand. Front Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226304</ArticleId><ArticleId IdType="pubmed">35757734</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway E.M., Mackman N., Warren R.Q., Wolberg A.S., Mosnier L.O., Campbell R.A., Gralinski L.E., Rondina M.T., van de Veerdonk F.L., Hoffmeister K.M., Griffin J.H., Nugent D., Moon K., Morrissey J.H. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022;22:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532&#x2013;1535.</Citation><ArticleIdList><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorch S.K., Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23:279&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">28267716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutua V., Gershwin L.J. A&#xa0;review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin Rev Allergy Immunol. 2021;61:194&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395212</ArticleId><ArticleId IdType="pubmed">32740860</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanch-Ruiz M.A., Ortega-Luna R., G&#xf3;mez-Garc&#xed;a G., Mart&#xed;nez-Cuesta M.&#xc1;., &#xc1;lvarez &#xc1;. Role of neutrophil extracellular traps in COVID-19 progression: an insight for effective treatment. Biomedicines. 2022;10:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8772933</ArticleId><ArticleId IdType="pubmed">35052711</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Yalavarthi S., Shi H., Gockman K., Zuo M., Madison J.A., Blair C., Weber A., Barnes B.J., Egeblad M., Woods R.J., Kanthi Y., Knight J.S. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Skendros P., Mitsios A., Chrysanthopoulou A., Mastellos D.C., Metallidis S., Rafailidis P., Ntinopoulou M., Sertaridou E., Tsironidou V., Tsigalou C., Tektonidou M., Konstantinidis T., Papagoras C., Mitroulis I., Germanidis G., Lambris J.D., Ritis K. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J&#xa0;Clin Invest. 2020;130:6151&#x2013;6157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598040</ArticleId><ArticleId IdType="pubmed">32759504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng H., Havervall S., Rosell A., Aguilera K., Parv K., von Meijenfeldt F.A., Lisman T., Mackman N., Thalin C., Phillipson M. Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19. Arterioscler Thromb Vasc Biol. 2021;41:988&#x2013;994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837697</ArticleId><ArticleId IdType="pubmed">33267662</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcanjo A., Logullo J., Menezes C.C.B., de Souza Carvalho Giangiarulo T.C., Dos Reis M.C., de Castro G.M.M., da Silva Fontes Y., Todeschini A.R., Freire-de-Lima L., Decot&#xe9;-Ricardo D., Ferreira-Pereira A., Freire-de-Lima C.G., Barroso S.P.C., Takiya C., Concei&#xe7;&#xe3;o-Silva F., Savino W., Morrot A. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) Sci Rep. 2020;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665044</ArticleId><ArticleId IdType="pubmed">33184506</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O'Sullivan J.M., Martin-Loeches I., Nadarajan P., Bannan C., Mallon P.W., Curley G.F., Preston R.J.S., Rehill A.M., McGonagle D., Ni Cheallaigh C., Baker R.I., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J&#xa0;Thromb Haemost. 2021;19:2546&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N, Steves C, MacDermott N, Morsella A, Angulo E, Winkelmann J, Bryndov&#xe1; L, Fronteira I, et&#xa0;al. European Observatory Policy Briefs. In: In the wake of the pandemic: Preparing for Long COVID. Copenhagen (Denmark): European Observatory on Health Systems and Policies&#xa9; World Health Organization 2021 (acting as the host organization for, and secretariat of, the European Observatory on Health Systems and Policies).&#xa0;2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/ [accessed November 29, 2021].</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessenbrock K., Krumbholz M., Schonermarck U., Back W., Gross W.L., Werb Z., Grone H.J., Brinkmann V., Jenne D.E. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15:623&#x2013;625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2760083</ArticleId><ArticleId IdType="pubmed">19448636</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe5;lin C., Aguilera K., Hall N.W., Marunde M.R., Burg J.M., Rosell A., Daleskog M., M&#xe5;nsson M., Hisada Y., Meiners M.J., Sun Z.W., Whelihan M.F., Cheek M.A., Howard S.A., Saxena-Beem S., Noubouossie D.F., Key N.S., Sheikh S.Z., Keogh M.C., Cowles M.W., et al. Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma. J&#xa0;Thromb Haemost. 2020;18:2732&#x2013;2743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8722705</ArticleId><ArticleId IdType="pubmed">32654410</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Chen J., Cai Y., Deng A., Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Br J Haematol. 2020;190:24&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267665</ArticleId><ArticleId IdType="pubmed">32379894</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood type distribution in Israel population. MAGEN DAVID ADOM IN ISRAEL (MDA) https://web.archive.org/web/20101126002311/http://mdais.org/362 [accessed December 26, 2021].</Citation></Reference><Reference><Citation>Ghahramani S., Tabrizi R., Lankarani K.B., Kashani S.M.A., Rezaei S., Zeidi N., Akbari M., Heydari S.T., Akbari H., Nowrouzi-Sohrabi P., Ahmadizar F. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res. 2020;25:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396942</ArticleId><ArticleId IdType="pubmed">32746929</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne B.K., Denorme F., Middleton E.A., Portier I., Rowley J.W., Stubben C., Petrey A.C., Tolley N.D., Guo L., Cody M., Weyrich A.S., Yost C.C., Rondina M.T., Campbell R.A. Platelet gene expression&#xa0;and&#xa0;function in patients with COVID-19. Blood. 2020;136:1317&#x2013;1329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Comer S.P., Cullivan S., Szklanna P.B., Weiss L., Cullen S., Kelliher S., Smolenski A., Murphy C., Altaie H., Curran J., O'Reilly K., Cotter A.G., Marsh B., Gaine S., Mallon P., McCullagh B., Moran N., N&#xed; &#xc1;inle F., Kevane B., Maguire P.B., et al. COVID-19 induces a hyperactive&#xa0;phenotype in circulating platelets. PLoS Biol. 2021;19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920383</ArticleId><ArticleId IdType="pubmed">33596198</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., Elmahi E., Prudon B., Green C., Felton T., Chadwick D., Rege K., Fegan C., Chappell L.C., Faust S.N., Jaki T., et al. Dexamethasone in hospitalized patients with Covid-19. N&#xa0;Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Alcoba G., Aebischer Perone S., Courvoisier D., Chappuis F., Guessous I., COVICARE TEAM COVID-19 Symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2021;174:723&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Radermecker C., Detrembleur N., Guiot J., Cavalier E., Henket M., d'Emal C., Vanwinge C., Cataldo D., Oury C., Delvenne P., Marichal T. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J&#xa0;Exp Med. 2020;217</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488867</ArticleId><ArticleId IdType="pubmed">32926097</ArticleId></ArticleIdList></Reference><Reference><Citation>Petito E., Falcinelli E., Paliani U., Cesari E., Vaudo G., Sebastiano M., Cerotto V., Guglielmini G., Gori F., Malvestiti M., Becattini C., Paciullo F., De Robertis E., Bury L., Lazzarini T., Gresele P. COVIR study investigators. Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019. J&#xa0;Infect Dis. 2021;223:933&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798977</ArticleId><ArticleId IdType="pubmed">33280009</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., Molteni E., Modat M., Jorge Cardoso M., May A., Ganesh S., Davies R., Nguyen L.H., Drew D.A., Astley C.M., Joshi A.D., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont A., Rauch A., Staessens S., Moussa M., Rosa M., Corseaux D., Jeanpierre E., Goutay J., Caplan M., Varlet P., Lefevre G., Lassalle F., Bauters A., Faure K., Lambert M., Duhamel A., Labreuche J., Garrigue D., De Meyer S.F., Staels B., et al. Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arterioscler Thromb Vasc Biol. 2021;41:1760&#x2013;1773.</Citation><ArticleIdList><ArticleId IdType="pubmed">33626910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner D.D., Frenette P.S. The vessel wall and its interactions. Blood. 2008;111:5271&#x2013;5281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2396724</ArticleId><ArticleId IdType="pubmed">18502843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gollomp K., Kim M., Johnston I., Hayes V., Welsh J., Arepally G.M., Kahn M., Lambert M.P., Cuker A., Cines D.B., Rauova L., Kowalska M.A., Poncz M. Neutrophil accumulation and NET release contribute to thrombosis in HIT. JCI Insight. 2018;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237233</ArticleId><ArticleId IdType="pubmed">30232279</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins P.V., Rawley O., Smith O.P., O'Donnell J.S. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157:653&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pubmed">22530883</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher R., Breakey N., Lammle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156948</ArticleId><ArticleId IdType="pubmed">32305740</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E.J., Walker A.J., Bhaskaran K., Bacon S., Bates C., Morton C.E., Curtis H.J., Mehrkar A., Evans D., Inglesby P., Cockburn J., McDonald H.I., MacKenna B., Tomlinson L., Douglas I.J., Rentsch C.T., Mathur R., Wong A.Y.S., Grieve R., Harrison D., et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad R., Eldosoky M., Fouad S.H., Elgendy A., Tawfeik A.M., Alboraie M., Abdelmaksoud M.F. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity. Innate Immun. 2021;27:240&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8054149</ArticleId><ArticleId IdType="pubmed">33646058</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Chen S., Liu M., Nie H., Lu H. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging Dis. 2020;11:668&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220287</ArticleId><ArticleId IdType="pubmed">32489711</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A., Okorie C., Marinkovic A., Patidar R., Younis K., Desai P., Hosein Z., Padda I., Mangat J., Altaf M. Comorbidity and its impact on patients with covid-19. SN Compr Clin Med. 2020;2:1069&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas M., Rahaman S., Biswas T.K., Haque Z., Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. 2020:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801974</ArticleId><ArticleId IdType="pubmed">33296901</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatim N., Boussier J., Chocron R., Hadjadj J., Philippe A., Gendron N., Barnabei L., Charbit B., Szwebel T.A., Carlier N., P&#xe8;ne F., Azoulay C., Khider L., Mirault T., Diehl J.L., Guerin C.L., Rieux-Laucat F., Duffy D., Kern&#xe9;is S., Smadja D.M., et al. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care. 2021;11:113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286043</ArticleId><ArticleId IdType="pubmed">34273008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladikou E.E., Sivaloganathan H., Milne K.M., Arter W.E., Ramasamy R., Saad R., Stoneham S.M., Philips B., Eziefula A.C., Chevassut T. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clin Med (Lond) 2020;20:e178&#x2013;e182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539718</ArticleId><ArticleId IdType="pubmed">32694169</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G., Pine A.B., Meizlish M.L., Chang C.H., Zhang H., Bahel P., Baluha A., Bar N., Bona R.D., Burns A.J., Dela Cruz C.S., Dumont A., Halene S., Hwa J., Koff J., Menninger H., Neparidze N., Price C., Siner J.M., Tormey C., et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575&#x2013;e582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbeke L., Van Mol P., Van Herck Y., De Smet F., Humblet-Baron S., Martinod K., et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun. 2021;12:1&#x2013;15. 4117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257697</ArticleId><ArticleId IdType="pubmed">34226537</ArticleId></ArticleIdList></Reference><Reference><Citation>Towards standardization of Neutrophil Extracellular Trap (NET) measurements in patient samples, Vascular Biology Subcommittee, International Society on Thrombosis and Haemostasis (ISTH), 2019. https://cdn.ymaws.com/www.isth.org/resource/resmgr/ssc/ssc_subcommittee_project_mar.pdf</Citation></Reference><Reference><Citation>Zuo Y., Zuo M., Yalavarthi S., Gockman K., Madison J.A., Shi H., Woodard W., Lezak S.P., Lugogo N.L., Knight J.S., Kanthi Y. Neutrophil extracellular traps and thrombosis in COVID-19. J&#xa0;Thromb Thrombolysis. 2021;51:446&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7642240</ArticleId><ArticleId IdType="pubmed">33151461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden H., Ibrahim N., Klopf J., Zagrapan B., Mauracher L.M., Hell L., Hofbauer T.M., Ondracek A.S., Schoergenhofer C., Jilma B., Lang I.M., Pabinger I., Eilenberg W., Neumayer C., Brostjan C. ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in&#xa0;vivo. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8062102</ArticleId><ArticleId IdType="pubmed">33886636</ArticleId></ArticleIdList></Reference><Reference><Citation>Sur Chowdhury C., Giaglis S., Walker U.A., Buser A., Hahn S., Hasler P. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther. 2014;16:R122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229860</ArticleId><ArticleId IdType="pubmed">24928093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalavarthi S., Gould T.J., Rao A.N., Mazza L.F., Morris A.E., N&#xfa;&#xf1;ez-&#xc1;lvarez C., Hern&#xe1;ndez-Ram&#xed;rez D., Bockenstedt P.L., Liaw P.C., Cabral A.R., Knight J.S. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol. 2015;67:2990&#x2013;3003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626310</ArticleId><ArticleId IdType="pubmed">26097119</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams S.T., Morton B., Alhamdi Y., Alsabani M., Lane S., Welters I.D., Wang G., Toh C.H. A&#xa0;novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients. Am J Respir Crit Care Med. 2019;200:869&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6812439</ArticleId><ArticleId IdType="pubmed">31162936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikacenic C., Moore R., Dmyterko V., West T.E., Altemeier W.A., Liles W.C., Lood C. Neutrophil extracellular traps (NETs) are increased in the alveolar spaces of patients with ventilator-associated pneumonia. Crit Care. 2018;22:358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6307268</ArticleId><ArticleId IdType="pubmed">30587204</ArticleId></ArticleIdList></Reference><Reference><Citation>Monitoring and treatment recommendations for COVID-19 patients. Israel ministry of health. The Israeli government website. https://www.gov.il/BlobFolder/reports/report-guide-treating-corona-patients/he/files_publications_corona_%D7%94%D7%9E%D7%9C%D7%A6%D7%95%D7%AA%20%D7%9C%D7%A0%D7%99%D7%98%D7%95%D7%A8%20%D7%95%D7%98%D7%99%D7%A4%D7%95%D7%9C%20%D7%91%D7%97%D7%95%D7%9C%D7%99%20COVID-19.pdf Updated 10 September 2020. [accessed September 23, 2022].</Citation></Reference><Reference><Citation>Assouline O., Ben-Chetrit E., Helviz Y., Kurd R., Leone M., Einav S. Experimental and compassionate drug use during the first wave of the COVID-19 pandemic: a retrospective single-center study. Adv Ther. 2021;38:5165&#x2013;5177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381349</ArticleId><ArticleId IdType="pubmed">34424502</ArticleId></ArticleIdList></Reference><Reference><Citation>de Brabander J., Michels E.H.A., van Linge C.C.A., Chouchane O., Douma R.A., Reijnders T.D.Y., Schuurman A.R., van Engelen T.S.R. Amsterdam UMC COVID-19 biobank study group; Wiersinga WJ, van der Poll T. Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward. Respir Res. 2022;23:145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9163524</ArticleId><ArticleId IdType="pubmed">35659223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M.H., Hassan A. Dexamethasone for the treatment of coronavirus disease (COVID-19): a review. SN Compr Clin Med. 2020;2:2637&#x2013;2646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599121</ArticleId><ArticleId IdType="pubmed">33163859</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillot C., Favresse J., Mullier F., Lecompte T., Dogne J.M., Douxfils J. NETosis and the immune system in COVID-19: mechanisms and potential treatments. Front Pharmacol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8376580</ArticleId><ArticleId IdType="pubmed">34421600</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshari R.S., Jyoti A., Dubey M., Kothari N., Kohli M., Bogra J., Barthwal M.K., Dikshit M. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS One. 2012;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3482178</ArticleId><ArticleId IdType="pubmed">23110185</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N, Steves C, MacDermott N, Morsella A, Angulo E, Winkelmann J, Bryndov&#xe1; L, Fronteira I, Gandr&#xe9; C, Or Z, Gerkens S, Sagan A, Sim&#xf5;es J, Ricciardi W, de Belvis AG, Silenzi A, Bernal-Delgado E, Estupi&#xf1;&#xe1;n-Romero F, et al. In the wake of the pandemic: Preparing for Long COVID [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., Chinchilli V.M. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruy&#xe8;re F., Stefic K., Gaudy-Graffin C., Grammatico-Guillon L., Bernard L. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel COVID-19 data tracker, Israel Ministry of Health. In: Israel Ministry of Health [accessed October 13, 2021].</Citation></Reference><Reference><Citation>Caricchio R., Abbate A., Gordeev I., Meng J., Hsue P.Y., Neogi T., Arduino R., Fomina D., Bogdanov R., Stepanenko T., Ruiz-Seco P., G&#xf3;nzalez-Garc&#xed;a A., Chen Y., Li Y., Whelan S., Noviello S., CAN-COVID Investigators Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial. JAMA. 2021;326:230&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8293025</ArticleId><ArticleId IdType="pubmed">34283183</ArticleId></ArticleIdList></Reference><Reference><Citation>Okur H.K., Yalcin K., Tastan C., Demir S., Yurtsever B., Karakus G.S., Kancagi D.D., Abanuz S., Seyis U., Zengin R., Hemsinlioglu C., Kara M., Yildiz M.E., Deliceo E., Birgen N., Pelit N.B., Cuhadaroglu C., Kocagoz A.S., Ovali E. Preliminary report of in&#xa0;vitro and in&#xa0;vivo effectiveness of dornase alfa on SARS-CoV-2 infection. New Microbes New Infect. 2020;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476504</ArticleId><ArticleId IdType="pubmed">32922804</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber A.G., Chau A.S., Egeblad M., Barnes B.J., Janowitz T. Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series. Mol Med. 2020;26:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522910</ArticleId><ArticleId IdType="pubmed">32993479</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F., Portier I., Rustad J.L., Cody M.J., de Araujo C.V., Hoki C., Alexander M.D., Grandhi R., Dyer M.R., Neal M.D., Majersik J.J., Yost C.C., Campbell R.A. Neutrophil extracellular traps regulate ischemic stroke brain injury. J&#xa0;Clin Invest. 2022;132</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106355</ArticleId><ArticleId IdType="pubmed">35358095</ArticleId></ArticleIdList></Reference><Reference><Citation>Denorme F., Rustad J.L., Portier I., Crandell J.L., de Araujo C.V., Cody M.J., Campbell R.A., Yost C.C. Neutrophil extracellular trap inhibition improves survival in neonatal mouse infectious peritonitis. Pediatr Res. 2023;93:862&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9331023</ArticleId><ArticleId IdType="pubmed">35902703</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>